featured
Second-Line Metformin Combination Therapies and HbA1c, Body Weight, and Glucose-Lowering Treatment Intensification
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Associations Between Second-Line Glucose-Lowering Combination Therapies With Metformin and HbA1c, Body Weight, Quality of Life, Hypoglycaemic Events, and Glucose-Lowering Treatment Intensification: The DISCOVER Study
Diabetes Obes Metab 2021 Apr 14;[EPub Ahead of Print], K Khunti, B Charbonnel, A Cooper, MB Gomes, L Ji, P Leigh, A Nicolucci, W Rathmann, MV Shestakova, A Siddiqui, F Tang, H Watada, H Chen,From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.